These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4599435)

  • 1. Side effects of depot fluphenazines.
    Ayd FJ
    Adv Biochem Psychopharmacol; 1974; 9(0):301-9. PubMed ID: 4599435
    [No Abstract]   [Full Text] [Related]  

  • 2. Side effects of depot fluphenazines.
    Ayd FJ
    Compr Psychiatry; 1974; 15(4):277-84. PubMed ID: 4607070
    [No Abstract]   [Full Text] [Related]  

  • 3. The depot fluphenazines: a reappraisal after 10 years' clinical experience.
    Ayd FJ
    Am J Psychiatry; 1975 May; 132(5):491-500. PubMed ID: 1091162
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy with injectable fluphenazines.
    Ayd FJ
    Curr Psychiatr Ther; 1976; 16():177-89. PubMed ID: 991628
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of depot fluphenazines: duration of action and incidence of side effects.
    Donlon PT; Axelrad AD; Tupin JP; Chien C
    Compr Psychiatry; 1976; 17(2):369-76. PubMed ID: 1253596
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidents and accidents during therapy with long-acting neuroleptics].
    Escande M; Vasquez Villareal S; Gayral L
    Ann Med Psychol (Paris); 1974 Jan; 1(1):112-20. PubMed ID: 4210849
    [No Abstract]   [Full Text] [Related]  

  • 7. Extrapyramidal symptoms in the course of fluphenazine treatment.
    Bastecký J; Vinar O; Taussigová D
    Act Nerv Super (Praha); 1972; 14(2):97-9. PubMed ID: 5040184
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognostic significance of selected side effects occurring in the course of prolonged-action fluphenazine treatment].
    Koślacz A; Popkowska N; Kulesza E; Lysikowska-Prokop L; Marmurowska-Michalowska H; Perzyński J
    Psychiatr Pol; 1977; 11(2):159-64. PubMed ID: 887674
    [No Abstract]   [Full Text] [Related]  

  • 9. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
    Schooler NR; Levine J
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):159-69. PubMed ID: 790413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting, antipsychotic agents and extrapyramidal side effects.
    Simpson GM
    Dis Nerv Syst; 1970 Sep; 31():Suppl:12-4. PubMed ID: 5476354
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
    Smulevich AB; Minsker EI; Mazaeva NA; Volkova RP; Lukanina SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):912-20. PubMed ID: 5050051
    [No Abstract]   [Full Text] [Related]  

  • 12. Iatrogenic morbidity in patients taking depot fluphenazine.
    Jose C; Mallya A; Mehta D; Evenson R; Holland R
    Am J Psychiatry; 1979 Jul; 136(7):976-7. PubMed ID: 453363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with a delayed-action preparation of fluphenazine].
    Schwingenheuer J
    Arzneimittelforschung; 1972 Nov; 22(11):1918-21. PubMed ID: 4633589
    [No Abstract]   [Full Text] [Related]  

  • 14. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract]   [Full Text] [Related]  

  • 15. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
    Johnson DA
    Br J Hosp Med; 1977 Jun; 17(6):546-58. PubMed ID: 18242
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary effects of Moditen-Retard].
    Fouks L
    Encephale; 1970; ():Suppl:14-8. PubMed ID: 5458708
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
    Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
    Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
    [No Abstract]   [Full Text] [Related]  

  • 19. Rigidity, hyperpyrexia and coma following fluphenazine enanthate.
    Meltzer HY
    Psychopharmacologia; 1973; 29(4):337-46. PubMed ID: 4707025
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
    Kurland AA; Dim BH; Olsson JE
    Dis Nerv Syst; 1970 Sep; 31():Suppl:18-23. PubMed ID: 5476356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.